Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial
A new study will evaluate whether a weekly dry powder nasal spray can boost natural defenses and prevent…
The $3,000 mattress cover company that billionaires love wants to become a healthcare company
Eight Sleep, the startup behind the $2,999 mattress cover that puts both Elon Musk and Mark Zuckerberg to…
You Want To Join a Clinical Trial. Here’s What To Know About the Hurdles.
Connecting people with clinical trials is complicated — even if people identify a promising match, there’s a slew…
Immune Molecules Play A Limited Role In ALS Progression
Newswise — Immune-related molecules change in motor neurons affected by amyotrophic lateral sclerosis (ALS), but they do not…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
IU Researchers Develop Explainable AI Score to Predict Dangerous Heart Attack Complication
Newswise — INDIANAPOLIS — Researchers at Indiana University School of Medicine have developed and tested a six-point scoring…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
En Carta Diagnostics Secures €5M to Advance At-Home Molecular Testing
En Carta Diagnostics, a startup developing molecular diagnostics for at-home use, has secured €5 million (approximately $5.8 million)…
Cutting-Edge Drug Shows Promise for Patients with NRAS-Driven Melanoma
Newswise — A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could be…
An Oral Ketamine Drug for Depression — Minus the Trip?
A novel oral ketamine drug was well tolerated and associated with reduced depressive symptoms in treatment-resistant depression (TRD)…
Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers
Newswise — In a new report of research, scientists at Johns Hopkins University School of Medicine and Johns…
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeutics, Inc. Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60…